First FRCR Examination Clinical Pharmacology module

List of Anti-Cancer Drugs

This supporting document sets out a list of drugs expected to be covered during core clinical
oncology training and which may be included in the clinical pharmacology module of the First
FRCR examination. It is anticipated that this will be reviewed annually to ensure current
practice is reflected. This version will apply to examinations held from Autumn 2014 until a
further version is published.

Cytotoxic agents
Alkylating agents
Bendamustine
Busulfan
Carmustine
Chlorambucil
Cyclophosphamide
Dacarbazine
Ifosfamide
Melphalan
Procarbazine

Anti-Tumour Antibiotics
Actinomycin D / Dactinomycin
Bleomycin
Daunorubicin
Doxorubicin
Doxorubicin (pegylated liposomal)
Epirubicin
Idarubicin
Mitomycin
Mitoxantrone
Plant Alkaloids/ Microtubule Inhibitors

Streptozocin

Etoposide

Temozolomide

Docetaxel

Anti- Metabolites

Asparaginase

Irinotecan
Paclitaxel

Capecitabine

Topotecan

Cytarabine

Vinblastine

5- Fluoro Uracil

Vincristine

Fludarabine

Vinorelbine

Gemcitabine

DNA Linking Agents

Methotrexate

Carboplatin

Pemetrexed

Cisplatin

Raltitrexed

Oxaliplatin

November2012p1

Biological agents

Fulvestrant

Alemtuzamab

Goserelin

BCG

Lanreotide

Bevacizumab

Lenalidomide

Cetuximab

Letrozole

Denosumab

Leuprorelin

Erlotinib

Medroxyprogesterone

Gefitinib

Megestrol

Imatinib

Mesna

Interferon

Octreotide

Ipilimumab

Stilboestrol

Lapatinib

Tamoxifen

Panitumumab

Thalidomide

Rituximab

Triptorelin

Sunitinib
Sorafenib
Temsirolimus
Trastuzumab

Bisphosphonates
Clodronate
Ibandronic acid
Pamidronate
Zolendronic acid

Hormones/other
Anastrozole
Abiraterone
Amifostine
Bexarotene
Bicalutamide
Buserelin
Cyproterone
Degarelix
Exemestane
Flutamide
Folinic acid
November2012p2